How GLP-1 medications are transforming diabetes and weight loss treatment
Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...
News Medical1d
Revolutionizing diabetes care with innovative targets and therapeutic options
A thorough examination of modern drugs that target particular receptors and metabolic pathways for glucose and fat metabolism is presented. Recent research has revealed innovative targets and ...
A weekly injection could replace painful daily treatment for rare genetic condition
Rutgers Health researchers have found that a weekly injection of diabetes medication could replace painful daily hormone ...
News Medical4d
Exercise improves brain insulin sensitivity and lowers dementia risk in older adults with prediabetes
Researchers explore the impact of exercise on the short-term regulation of insulin pathways in brain circuits.
eLife5d
Neuronal Detection Triggers Systemic Digestive Shutdown in Response to Adverse Food Sources
Southwest United Graduate School, Yunnan Key Laboratory of Cell Metabolism and Diseases, State Key Laboratory of Conservation and Utilization of Bio-resources in Yunnan Center for Life Sciences, ...
BioWorld5d
PTP1B allosteric inhibitor enhances glucose uptake in insulin resistance models
Tyrosine-protein phosphatase non-receptor type 1 (PTP1B) acts as a negative regulator of the insulin signaling pathway by dephosphorylating both the insulin receptor (IR) and the insulin receptor ...